Who is sponsoring NCT04418102?

NCT04418102 is sponsored by King's College London.

What drugs are being tested in NCT04418102?

Interventions in NCT04418102: Palmitic acid rich interesterified fat, Stearic acid rich interesterified fat.

What condition does NCT04418102 study?

NCT04418102 studies Cardiometabolic Health.

Is NCT04418102 still recruiting?

NCT04418102 is currently completed. Last updated 19 April 2023.

Last reviewed 2023-04-19 · How we verify

NCT04418102: InterSat

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The InterSat Study

Completed NA Last updated 19 April 2023

What this trial tests

NA trial testing Palmitic acid rich interesterified fat in Cardiometabolic Health in 51 participants. Completed in 25 August 2022.

Timeline

1 February 2020

Primary endpoint
25 August 2022

25 August 2022

Quick facts

Lead sponsor	King's College London
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	basic science
Enrollment	51
Start date	1 February 2020
Primary completion	25 August 2022
Estimated completion	25 August 2022
Sites	2 locations across United Kingdom, Netherlands

Drugs / interventions tested

Palmitic acid rich interesterified fat
Stearic acid rich interesterified fat

Conditions studied

Cardiometabolic Health — all drugs for Cardiometabolic Health →

Sponsor

King's College London

Who can join

Adults 35 to 65, any sex, with Cardiometabolic Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In response to the removal of trans fats from our foods, the food industry now uses interesterified (IE) fats. Randomly interesterified (IE) fats rich in palmitic (Europe) and stearic (North America) acids are the most commonly used IE fats by the food industry. Despite their widespread use, there has been no published research on the acute and chronic cardio-metabolic health effects of the most commonly consumed palmitic and stearic acid rich IE fats. The aim of InterSat is to investigate the postprandial and chronic effects of a diet rich in IE fats on cardiometabolic health.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The effects of consumption of interesterified fats rich in palmitic acid compared with stearic acid on intermediary markers of cardiometabolic disease risk: a randomized controlled trial in healthy adults.
Hall WL, Wood E, Joris PJ, Smith HA, et al · · 2025 · cited 1× · PMID 40975239 · DOI 10.1016/j.ajcnut.2025.09.025

Verify or expand the search:

Other recruiting trials for Cardiometabolic Health

Currently open trials in the same condition.

NCT06348082 — Project Women's Insomnia Sleep Health Equity Study (WISHES) · NA · recruiting
NCT06950775 — The Neighborhood & Health Study · recruiting
NCT06570707 — Evaluating the Impact of a School-based Fruit and Vegetable Co-op on Cardiometabolic Child and Parents Health in a Persi · NA · recruiting
NCT06535178 — The Influence of Sleep on Cardiovascular Outcomes · NA · recruiting
NCT06347094 — Precision Nutrition to Improve Cardiometabolic Health With Dietary (Poly)Phenols · NA · recruiting

Other King's College London trials

Trials by the same sponsor.

NCT07357064 — Professional Decision Making in Childbirth. · not yet recruiting
NCT07341087 — Skin Inflammation in Perimenopause: A Probiotic Intervention Proof of Concept Trial · NA · recruiting
NCT07228962 — Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies · not yet recruiting
NCT07365722 — Comparison of Two Non-surgical Procedure to Manage Gum Disease Around Implants. · NA · not yet recruiting
NCT07378488 — Dance/Movement Therapy for Functional Neurological Disorder · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04418102 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by King's College London
Last refreshed: 19 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04418102.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing